Tag: Nasdaq:PLRX
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
- PLN-74809 Phase 2a PET Imaging Trial Continues to Enroll with Preliminary Data Expected First Half of 2021 - PLN-74809 Phase 2a...